Efficacy and Safety Study of Peginterferon Alfa-2b in Chinese Chronic Hepatitis C Patients

Clinical trial NCT01581398 · COMPLETED

Trial details

NCT number: NCT01581398
Sponsor: Xiamen Amoytop Biotech Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Hepatitis C

Start date: 2012-04-01
Primary completion: 2014-04-01
Enrollment: 770

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.